IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enavate Sciences GP, LLC

Q1 2025 Holdings

Filed 2025-05-15 | 6 holdings | $132.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Immunome Inc(IMNM)COM45257U108$32.1M4,768,58324.2%
Zenas Biopharma Inc(ZBIO)COM98937L105$29.7M3,761,35922.4%
Sionna Therapeutics Inc(SION)COM829401108$25.9M2,478,03019.5%
Camp4 Therapeutics Corp(CAMP)COM13463J101$15.1M3,785,80211.4%
Upstream BIO Inc(UPB)COM91678A107$15.1M2,459,70311.3%
Compass Therapeutics Inc(CMPX)COM20454B104$14.8M7,788,15011.1%